Drug Monitoring Assess Panel, Comprehensive, Qualitative, Urine
Test Code
Clinical Significance
Drug Monitoring Assess Panel, Comprehensive, Qualitative, Urine - In an emergency medicine or acute care setting, a definitive qualitative assessment of the presence of different drugs can be critical to patient care. Absence of an expected drug could suggest poor adherence or diversion whereas detection of a non-prescribed licit or illicit drug could indicate substance misuse or toxicity. Discrepancies between expected and actual results also call attention to potential medical factors affecting drug disposition. Drug cutoffs in this panel are targeted to detect potentially toxic or overdose situations. This assay is not intended for monitoring routine use of prescription substances.
Test Resources
Test Details
Methodology
Reference Range(s)
| Summary | Negative (ng/mL) |
Alternative Name(s)
Preferred Specimen(s)
3 mL random urine
Minimum Volume
1 mL
Transport Container
Plastic urine container
Transport Temperature
Room temperature
Specimen Stability
- Room temperature: 14 days
Refrigerated: 21 days
Frozen: 30 days
Reject Criteria
Preserved urine
Setup Schedule
Refrigerated: 21 days
Frozen: 30 days